Virologic Response to Tipranavir-Ritonavir or Darunavir-Ritonavir Based Regimens in Antiretroviral Therapy Experienced HIV-1 Patients: A Meta-Analysis and Meta-Regression of Randomized Controlled Clinical Trials-Reference-Cited by-同舟云学术

Virologic Response to Tipranavir-Ritonavir or Darunavir-Ritonavir Based Regimens in Antiretroviral Therapy Experienced HIV-1 Patients: A Meta-Analysis and Meta-Regression of Randomized Controlled Clinical Trials

Published:2013-04-04 Issue:4 Volume:8 Page:e60814
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Berhan Asres,Berhan Yifru

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference39 articles.

1. Joint United Nations Programme on HIV/AIDS (UNAIDS) (2012) Together we will end AIDS. Available: http://www.google.com.et/url. Accessed 2012 Oct.

2. Long term probability of detection of HIV-1 drug resistance after starting antiretroviral therapy in routine clinical practice;AN Phillips;AIDS,2005

3. Transmitted drug resistance in persons with acute/early HIV-1 in San Francisco, 2002-2009;V Jain;PLoS ONE,2010

4. Cross-resistance patterns among HIV protease inhibitors;M Kozal;AIDS Patient Care ST,2004

5. Increased resilience to the development of drug resistance with modern boosted protease inhibitor– based highly active antiretroviral therapy;VD Lima;J Infect Dis,2008

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Virologic Effectiveness of Abacavir/Lamivudine with Darunavir/Ritonavir Versus Other Protease Inhibitors in Treatment-Experienced HIV-Infected Patients in Clinical Practice;Clinical Drug Investigation;2016-09-01

2. Effectiveness, durability, and safety of darunavir/ritonavir in HIV-1-infected patients in routine clinical practice in Italy: a postauthorization noninterventional study;Drug Design, Development and Therapy;2016-05

3. Organofluorine Pharmaceuticals;Organofluorine Compounds in Biology and Medicine;2015

4. Liver Enzyme Elevation During Darunavir-Based Antiretroviral Treatment in HIV-1–Infected Patients With or Without Hepatitis C Coinfection: Data from the ICONA Foundation Cohort;HIV Clinical Trials;2014-08